pharmaceuticalWhile all analytical data that is used for decision-making needs to be of known and documented quality, the pharmaceutical industry in particular demands undisputable results and extensive supportive documentation. The decisions based upon analytical results that support drug discovery, development, and manufacturing can have significant repercussions on public health, product quality, regulatory compliance, and ultimately the drug manufacturer’s financial status. For over the decade, the services provided by Brooks Applied Labs have supported drug release testing, clean up efficiencies of catalysts, impurity identification, lot monitoring, and investigations into bioreactor performance variability.

Through our experience with nearly all facets of the industry, our involvement has saved our clients hundreds of millions of dollars on method development/validation, synthesis inefficiencies, side product formation, API stability, and most importantly the ability to deliver life-saving drugs to patients who need it.

Scientists at Brooks Applied Labs have the knowledge and experience to identify the most appropriate preparatory and analytical techniques for the most complex pharmaceutical molecules and target elements as we have tested thousands of different materials over the years.

Brooks Applied Labs has been audited by our pharmaceutical clients, third party accreditation services, as well as the FDA. These audits play an invaluable role in our commitment to continuous improvement of our quality systems and support of our clients’ needs. Our approach to quality constantly adjusts with the understanding that the regulatory environment can and will change, necessitating a proactive approach by both our clients and Brooks Applied Labs.

Contact us to find out how your quality and process objectives can be met more efficiently or read more about our services by clicking on any of our brochures below.

Pharma BIO Destable Pharma BIO Pipeline Pharma BIO impurtiy Testing Pharma BIO Risk